These studies attribute the association to the role of TET1 in hypomethylating and therefore reactivating tumor-suppressor genes such as TP53 and TIMP, which in turn would lead to suppression of tumor development, invasion, and therefore better overall survival. The gene discussed is TP53; the disease is neoplasm.